To further analyze whether the observed differences could be related to technical issues or biologic relevance, we next evaluated the prognostic value of HSF1 mRNA expression using overall survival and relapse-free survival as endpoints in subsets of breast cancer represented in 11 microarray datasets (GOBO tool). Here, HSF1 is linked to breast carcinoma.